Document is current
Any future updates will be listed below
-
Authors
Zuo, Yu
Warnock, Mark
Harbaugh, Alyssa
Yalavarthi, Srilakshmi
Gockman, Kelsey
Zuo, Melanie
Madison, Jacqueline A.
Knight, Jason S.
Kanthi, Yogendra
Lawrence, Daniel A.
-
Funding
Funding for this research was provided by:
Rheumatology Research Foundation
National Heart, Lung, and Blood Institute (HL115138, HL131993, HL055374)
Lupus Research Alliance
Burroughs Wellcome Fund
A. Alfred Taubman Medical Research Institute
Falk Medical Research Trust Catalyst Award
American Venous Forum
- License Information
-
More Information
Article History
Received: 23 October 2020
Accepted: 14 December 2020
First Online: 15 January 2021
Completing interests
: Daniel A. Lawrence is a member of the board and holds equity in MDI Therapeutics which is developing therapeutic inhibitors of PAI-1. All other authors report that they have no conflicts of interest.
